Literature DB >> 24363065

Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion.

Kristen Martins-Taylor1, Jack S Hsiao, Pin-Fang Chen, Heather Glatt-Deeley, Adam J De Smith, Alexandra I F Blakemore, Marc Lalande, Stormy J Chamberlain.   

Abstract

Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two neurodevelopmental disorders most often caused by deletions of the same region of paternally inherited and maternally inherited human chromosome 15q, respectively. AS is a single gene disorder, caused by the loss of function of the ubiquitin ligase E3A (UBE3A) gene, while PWS is still considered a contiguous gene disorder. Rare individuals with PWS who carry atypical microdeletions on chromosome 15q have narrowed the critical region for this disorder to a 108 kb region that includes the SNORD116 snoRNA cluster and the Imprinted in Prader-Willi (IPW) non-coding RNA. Here we report the derivation of induced pluripotent stem cells (iPSCs) from a PWS patient with an atypical microdeletion that spans the PWS critical region. We show that these iPSCs express brain-specific portions of the transcripts driven by the PWS imprinting center, including the UBE3A antisense transcript (UBE3A-ATS). Furthermore, UBE3A expression is imprinted in most of these iPSCs. These data suggest that UBE3A imprinting in neurons only requires UBE3A-ATS expression, and no other neuron-specific factors. These data also suggest that a boundary element lying within the PWS critical region prevents UBE3A-ATS expression in non-neural tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24363065      PMCID: PMC3976333          DOI: 10.1093/hmg/ddt628

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

1.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes.

Authors:  Stormy J Chamberlain; Pin-Fang Chen; Khong Y Ng; Fany Bourgois-Rocha; Fouad Lemtiri-Chlieh; Eric S Levine; Marc Lalande
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region.

Authors:  I Boccaccio; H Glatt-Deeley; F Watrin; N Roëckel; M Lalande; F Muscatelli
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

3.  Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.

Authors:  Christoph Bock; Evangelos Kiskinis; Griet Verstappen; Hongcang Gu; Gabriella Boulting; Zachary D Smith; Michael Ziller; Gist F Croft; Mackenzie W Amoroso; Derek H Oakley; Andreas Gnirke; Kevin Eggan; Alexander Meissner
Journal:  Cell       Date:  2011-02-04       Impact factor: 41.582

4.  Nutritional phases in Prader-Willi syndrome.

Authors:  Jennifer L Miller; Christy H Lynn; Danielle C Driscoll; Anthony P Goldstone; June-Anne Gold; Virginia Kimonis; Elisabeth Dykens; Merlin G Butler; Jonathan J Shuster; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2011-04-04       Impact factor: 2.802

5.  Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.

Authors:  Linyan Meng; Richard E Person; Arthur L Beaudet
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

6.  Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.

Authors:  Aba Somers; Jyh-Chang Jean; Cesar A Sommer; Amel Omari; Christopher C Ford; Jason A Mills; Lei Ying; Andreia Gianotti Sommer; Jenny M Jean; Brenden W Smith; Robert Lafyatis; Marie-France Demierre; Daniel J Weiss; Deborah L French; Paul Gadue; George J Murphy; Gustavo Mostoslavsky; Darrell N Kotton
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

7.  Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells.

Authors:  Hui Zeng; Min Guo; Kristen Martins-Taylor; Xiaofang Wang; Zheng Zhang; Jung Woo Park; Shuning Zhan; Mark S Kronenberg; Alexander Lichtler; Hui-Xia Liu; Fang-Ping Chen; Lixia Yue; Xue-Jun Li; Ren-He Xu
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

8.  Derivation and isolation of NKX2.1-positive basal forebrain progenitors from human embryonic stem cells.

Authors:  Noélle D Germain; Erin C Banda; Sandy Becker; Janice R Naegele; Laura B Grabel
Journal:  Stem Cells Dev       Date:  2013-03-05       Impact factor: 3.272

9.  Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.

Authors:  Hsien-Sung Huang; John A Allen; Angela M Mabb; Ian F King; Jayalakshmi Miriyala; Bonnie Taylor-Blake; Noah Sciaky; J Walter Dutton; Hyeong-Min Lee; Xin Chen; Jian Jin; Arlene S Bridges; Mark J Zylka; Bryan L Roth; Benjamin D Philpot
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

10.  Topoisomerases facilitate transcription of long genes linked to autism.

Authors:  Ian F King; Chandri N Yandava; Angela M Mabb; Jack S Hsiao; Hsien-Sung Huang; Brandon L Pearson; J Mauro Calabrese; Joshua Starmer; Joel S Parker; Terry Magnuson; Stormy J Chamberlain; Benjamin D Philpot; Mark J Zylka
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

View more
  28 in total

Review 1.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

Review 2.  Angelman Syndrome.

Authors:  Seth S Margolis; Gabrielle L Sell; Mark A Zbinden; Lynne M Bird
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

3.  Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs.

Authors:  Estela Cruvinel; Tara Budinetz; Noelle Germain; Stormy Chamberlain; Marc Lalande; Kristen Martins-Taylor
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

4.  A bipartite boundary element restricts UBE3A imprinting to mature neurons.

Authors:  Jack S Hsiao; Noelle D Germain; Andrea Wilderman; Christopher Stoddard; Luke A Wojenski; Geno J Villafano; Leighton Core; Justin Cotney; Stormy J Chamberlain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

Review 5.  Transflammation: Innate immune signaling in nuclear reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Adv Drug Deliv Rev       Date:  2017-09-13       Impact factor: 15.470

Review 6.  Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Antioxid Redox Signal       Date:  2018-04-26       Impact factor: 8.401

Review 7.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

8.  Enhanced Nociception in Angelman Syndrome Model Mice.

Authors:  Eric S McCoy; Bonnie Taylor-Blake; Megumi Aita; Jeremy M Simon; Benjamin D Philpot; Mark J Zylka
Journal:  J Neurosci       Date:  2017-09-20       Impact factor: 6.167

Review 9.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

Review 10.  A practical guide to induced pluripotent stem cell research using patient samples.

Authors:  Katherine E Santostefano; Takashi Hamazaki; Nikolett M Biel; Shouguang Jin; Akihiro Umezawa; Naohiro Terada
Journal:  Lab Invest       Date:  2014-08-04       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.